Eli Lilly’s experimental Alzheimer’s treatment was ruled a failure in two earlier trials. But when investigators combined solanezumab’s data from both tests, they discovered that cognitive...
Protective gene mutation gives hope to Alzheimer’s drug development
By
McKnight's Staff
Jul 16, 2012
Alzheimer’s researchers got a huge boost last week with the publication of a study showing that a rare genetic mutation prevents the buildup of beta amyloid in the brain.